Stcube & Co., Inc.
Records under this name other than the patents Stcube & Co., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,875,920 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof now held by Board of Regents, the University of Texas System In force · High confidence | In force | High confidence | |
| US 11,970,534 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof now held by Board of Regents, the University of Texas System In force · High confidence | In force | High confidence | |
| US 12,059,474 | Methods for Selecting Antibodies That Specifically Bind Glycosylated Immune Checkpoint Proteins now held by Board of Regents, the University of Texas System In force · High confidence | In force | High confidence | |
| 15/575,325 | Screening Methods for Targets for Cancer Therapy now held by Board of Regents, the University of Texas System Abandoned Abandoned Jul 7, 2025 | Abandoned | Abandoned Jul 7, 2025 | |
| 16/618,042 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof Abandoned Abandoned Nov 15, 2024 | Abandoned | Abandoned Nov 15, 2024 | |
| 17/764,098 | Antibodies Specific to Glycosylated CTLA-4 and Methods of Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/066,879 | Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/625,891 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof now held by Board of Regents, the University of Texas System Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/763,821 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/847,179 | BTN1A1 Binding Proteins and Methods of Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |